Adenovirus-based vaccine prevents pneumonia in ferrets challenged with the SARS coronavirus and stimulates robust immune responses in macaques

[1]  G. Kobinger,et al.  Chimpanzee adenovirus vaccine protects against Zaire Ebola virus. , 2006, Virology.

[2]  J. Gonzalez,et al.  Fruit bats as reservoirs of Ebola virus , 2005, Nature.

[3]  Jonathan H. Epstein,et al.  Bats Are Natural Reservoirs of SARS-Like Coronaviruses , 2005, Science.

[4]  Kwok-Hung Chan,et al.  Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Deborah R. Taylor.  Obstacles and advances in SARS vaccine development , 2005, Vaccine.

[6]  James M. Wilson,et al.  SARS vaccine: progress and challenge. , 2005, Cellular & molecular immunology.

[7]  Hao Shen,et al.  Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein , 2005, Virology.

[8]  R. Proulx,et al.  Immunization with Modified Vaccinia Virus Ankara-Based Recombinant Vaccine against Severe Acute Respiratory Syndrome Is Associated with Enhanced Hepatitis in Ferrets , 2004, Journal of Virology.

[9]  M. St. Claire,et al.  Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys , 2004, Virology.

[10]  R. Crystal,et al.  Resolution of Primary Severe Acute Respiratory Syndrome-Associated Coronavirus Infection Requires Stat1 , 2004, Journal of Virology.

[11]  R. Crystal,et al.  Macaque Model for Severe Acute Respiratory Syndrome , 2004, Journal of Virology.

[12]  John A. Maher,et al.  The Ferret: An Animal Model to Study Influenza Virus , 2004, Lab Animal.

[13]  M. Lock,et al.  Characterization of a family of chimpanzee adenoviruses and development of molecular clones for gene transfer vectors. , 2004, Human gene therapy.

[14]  T. Kuiken,et al.  Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets , 2004, The Lancet.

[15]  J. Sung,et al.  Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome , 2004, Clinical and experimental immunology.

[16]  Michelle M. Packard,et al.  Prior Infection and Passive Transfer of Neutralizing Antibody Prevent Replication of Severe Acute Respiratory Syndrome Coronavirus in the Respiratory Tract of Mice , 2004, Journal of Virology.

[17]  W. Bellini,et al.  Effects of a SARS-associated coronavirus vaccine in monkeys , 2003, The Lancet.

[18]  M. R. Delgado Alvira,et al.  High throughput creation of recombinant adenovirus vectors by direct cloning, green-white selection and I-Sce I-mediated rescue of circular adenovirus plasmids in 293 cells , 2003, Gene Therapy.

[19]  Obi L. Griffith,et al.  The Genome Sequence of the SARS-Associated Coronavirus , 2003, Science.

[20]  Yi Guan,et al.  Lung pathology of fatal severe acute respiratory syndrome , 2003, The Lancet.

[21]  Z. Xiang,et al.  A Simian Replication-Defective Adenoviral Recombinant Vaccine to HIV-1 Gag 1 , 2003, The Journal of Immunology.

[22]  P. Earl,et al.  Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. , 2002, Vaccine.

[23]  Thomas Rowe,et al.  Pathogenesis of Avian Influenza A (H5N1) Viruses in Ferrets , 2002, Journal of Virology.

[24]  James G. Herndon,et al.  Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine , 2001, Science.

[25]  A. Mccarthy.  Development , 1996, Current Opinion in Neurobiology.

[26]  Yamamura Ken-ichi,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .

[27]  H. Niwa,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.

[28]  S. Keely,et al.  Assessment of signs of influenza illness in the ferret model. , 1989, Journal of virological methods.

[29]  L. Reed,et al.  A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .

[30]  Malik Peiris,et al.  Aetiology: Koch's postulates fulfilled for SARS virus , 2003, Nature.

[31]  Albert D. M. E. Osterhaus,et al.  SARS virus infection of cats and ferrets , 2003, Nature.

[32]  J. Wilson,et al.  A cell line for high-yield production of E1-deleted adenovirus vectors without the emergence of replication-competent virus. , 2000, Human gene therapy.